Minimum clinically important differences identified for commonly used depression rating scales
Authors:
- Sarah C. MassonSMSarah C. Masson
- Aaron M. TejaniATAaron M. Tejani
- 1 July 2013
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 66 (7) , 805-807
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Antidepressant Drug Effects and Depression SeverityJAMA, 2010
- The clinical relevance of changes in the Montgomery–Asberg Depression Rating Scale using the minimum clinically important difference approachCurrent Medical Research and Opinion, 2008
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug AdministrationPLOS Medicine, 2008
- Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT RecommendationsThe Journal of Pain, 2008
- What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder?The Journal of Clinical Psychiatry, 2006
- Gradations of clinical severity and sensitivity to change assessed with the Beck Depression Inventory-II in Japanese patients with depressionPsychiatry Research, 2005
- The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionBiological Psychiatry, 2003
- Defining remission by cut off score on the MADRS: selecting the optimal valueJournal of Affective Disorders, 2002